Literature DB >> 11438616

18F-FDG PET detection of colonic adenomas.

S Yasuda1, H Fujii, T Nakahara, N Nishiumi, W Takahashi, M Ide, A Shohtsu.   

Abstract

UNLABELLED: The adenomatous polyp of the colon is clinically important as a precursor of colonic cancer. The aim of this preliminary study was to evaluate the potential usefulness of (18)F-FDG PET for detecting adenomatous polyps of the colon.
METHODS: We performed a retrospective study of 110 subjects who underwent both PET study and total colonoscopy. On nonattenuation-corrected PET images, focal distinct FDG accumulation along the large intestine was considered a positive finding, and the PET results were compared with colonoscopic findings. Histology and adenoma size were determined by polypectomy.
RESULTS: Fifty-nine adenomatous polyps, 5-30 mm in size, were found in 30 subjects by total colonoscopy. PET findings were positive for 14 of the 59 adenomas (24%). The positivity rate for PET images rose with the increase in size of the adenomas; it was 90% in adenomas (9/10) that were > or =13 mm. The overall false-positive rate was 5.5% (6/110 subjects).
CONCLUSION: Increased glucose metabolism is observed in colonic adenomas, and detectability with PET increases with the increase in adenoma size. Adenomas are premalignant lesions, and it is important to realize that colonic adenomas may be found incidentally during an FDG PET study.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11438616

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  37 in total

1.  Liver-specific contrast agent-enhanced magnetic resonance and ¹⁸F-fluorodeoxyglucose positron emission tomography findings of hepatocellular adenoma: report of a case.

Authors:  Tatsuaki Sumiyoshi; Michihisa Moriguchi; Hideyuki Kanemoto; Kouiku Asakura; Keiko Sasaki; Teiichi Sugiura; Takashi Mizuno; Katsuhiko Uesaka
Journal:  Surg Today       Date:  2011-12-10       Impact factor: 2.549

Review 2.  18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies.

Authors:  B B Chin; R L Wahl
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

3.  Detection of relevant colonic neoplasms with PET/CT: promising accuracy with minimal CT dose and a standardised PET cut-off.

Authors:  Wolfgang Luboldt; Teresa Volker; Bärbel Wiedemann; Klaus Zöphel; Ursula Wehrmann; Arne Koch; Todd Toussaint; Nasreddin Abolmaali; Markus Middendorp; Daniela Aust; Jörg Kotzerke; Frank Grünwald; Thomas J Vogl; Hans-Joachim Luboldt
Journal:  Eur Radiol       Date:  2010-05-26       Impact factor: 5.315

4.  Is whole-body FDG-PET valuable for health screening? Against.

Authors:  Matthias Weckesser; Otmar Schober
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03       Impact factor: 9.236

5.  Endoscopic evaluation of gastrointestinal lesions noted incidentally on PET scanning.

Authors:  Donald S David; Glen R Gibson; Frederic Grannis
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

6.  PET/CT colonography in patients with colorectal polyps: a feasibility study.

Authors:  Pier Paolo Mainenti; Barbara Salvatore; Dario D'Antonio; Teresa De Falco; Giovanni Domenico De Palma; Francesco Paolo D'Armiento; Luigi Bucci; Leonardo Pace; Marco Salvatore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-05-11       Impact factor: 9.236

7.  Pretreatment with diphenoxylate hydrochloride/atropine sulfate (Lomotil) does not decrease physiologic bowel FDG activity on PET/CT scans of the abdomen and pelvis.

Authors:  Robert Murphy; Kirk M Doerger; Mark A Nathan; Val J Lowe
Journal:  Mol Imaging Biol       Date:  2008-11-27       Impact factor: 3.488

8.  Ability of FDG-PET to detect all cancers in patients with familial adenomatous polyposis, and impact on clinical management.

Authors:  Mariëtte C A van Kouwen; Joost P H Drenth; J Han J M van Krieken; Harry van Goor; Pieter Friederich; Wim J G Oyen; Fokko M Nagengast
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-11-16       Impact factor: 9.236

9.  Role of low-dose, noncontrast computed tomography from integrated positron emission tomography/computed tomography in evaluating incidental 2-deoxy-2-[F-18]fluoro-D-glucose-avid colon lesions.

Authors:  S T Lee; T Tan; A M T Poon; H B Toh; S Gill; S U Berlangieri; E Kraft; A J Byrne; K Pathmaraj; G J O'Keefe; N Tebbutt; A M Scott
Journal:  Mol Imaging Biol       Date:  2007-11-10       Impact factor: 3.488

10.  Equating salivary lactate dehydrogenase (LDH) with LDH-5 expression in patients with oral squamous cell carcinoma: An insight into metabolic reprogramming of cancer cell as a predictor of aggressive phenotype.

Authors:  Tajindra Singh Saluja; Anita Spadigam; Anita Dhupar; Shaheen Syed
Journal:  Tumour Biol       Date:  2015-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.